Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Druss, B. G. Articles by Marcus, S. C. Search for Related Content PubMed Citation Articles by Druss, B. G. Articles by Marcus, S. C. Posttraumatic Stress Disorder Antidepressants Atypical Neuroleptics Conventional Neuroleptics

Use of Psychotropic Medications Before and After Sept. 11, 2001

OBJECTIVE: This study examined patterns of psychotropic medication use after the Sept. 11, 2001, terrorist attacks. METHOD: It drew from two large pharmacy data sets, one providing nationally representative aggregate projections for all U.S. prescriptions (156.9 million claims for psychotropic medications during the study period) and a second from the nation’s largest pharmacy benefit management organization (36.4 million enrollees per month), 4.1% of whom had a prescription for a psychotropic medication during the study period. Analyses examined use of antidepressant, antipsychotic, anxiolytic, and hypnotic medications in the 12 weeks before and after Sept. 11, 2001, compared with the same weeks during 2000. RESULTS: Nationally and in Washington, D.C., there was no evidence of an increase in overall prescriptions, new prescriptions, or daily doses for psychotropic medications. In New York City, there was an increase in the proportion of existing users with psychotropic dose increases in the weeks after the attacks (16.9% in 2001 versus 13.6% in 2000) but no significant increase in the rate of new psychotropic prescriptions. CONCLUSIONS: For most of the nation, the distress associated with the terrorist attacks was not accompanied by a commensurate increase in the use of psychotropic medications. In New York City, there was a statistically significant but modest increase in the proportion of individuals with dose increases in their psychotropic medications.

This article has been cited by other articles:

				I. Levav, I. Novikov, A. Grinshpoon, J. Rosenblum, and A. Ponizovsky Health Services Utilization in Jerusalem Under Terrorism Am J Psychiatry, August 1, 2006; 163(8): 1355 - 1361. [Abstract] [Full Text] [PDF]

				J. Rosack 9/11 Didn't Produce Jump In Psychoactive Drug Use Psychiatr News, September 3, 2004; 39(17): 35 - 35. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us